-
1741
-
1742
The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma
Published 2021-01-01Get full text
Article -
1743
-
1744
-
1745
A multi-modal dental dataset for semi-supervised deep learning image segmentation
Published 2025-01-01Get full text
Article -
1746
-
1747
-
1748
-
1749
-
1750
Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus
Published 2025-01-01“…Xiaowei Li,* Kunkun Cao,* Zhigang Fu,* Xiaoxia Chen, Jiaming Zhong, Li Liu, Ning Ding, Xiaoli Zhang, Zengqiang Qu, Lijun Zhu, Jian Zhai Department II of Interventional Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jian Zhai; Lijun Zhu, Department II of Interventional Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, People’s Republic of China, Email jianzhai1979@126.com; lijun_zhush@163.comPurpose: To assess the activity and toxicity of hepatic arterial infusion chemotherapy (HAIC)+tislelizumab+lenvatinib (HAIC+tisle+len) in hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) type IV (Vp4 hCC) in a real-world context.Methods: Fifty-five patients, with Vp4 hCC receiving HAIC+tisle+len therapy from April 2021 to December 2022, were analyzed retrospectively. …”
Get full text
Article -
1751
-
1752
Association between occupational exposure to gasoline and anemia: a retrospective cohort study in China
Published 2025-01-01Get full text
Article -
1753
-
1754
Polydopamine grafting polyether ether ketone to stabilize growth factor for efficient osteonecrosis repair
Published 2025-01-01Get full text
Article -
1755
-
1756
-
1757
-
1758
-
1759
-
1760